High-dose chemotherapy (HDC) and stem-cell rescue as salvage treatment for germ cell testicular tumors in second- and third-line, and outside clinical trials
Ronchi, Fernanda Carneiro, Araujo, Daniel Vilarim, Urvanegia, Ana Claudia Machado, Rinck, José Augusto
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
Analysis of predictive clinical markers of outcome in patients with metastatic clear-cell renal cell carcinoma (mRCC) treated with tyrosine-kinases inhibitors (TKI) in first line: A C Camargo Cancer Center experience
Ferreira, Camila Nassif Martins, Rinck, José Augusto, Albuquerque, Christiane Silveira Marinho, Costa, Tatiana Vieira, Urvanegia, Ana Claudia Machado, Corassa, Marcelo, Formiga, Maria Nirvana Cruz, Lourenço Abbade Dettino, Aldo, Tariki, Milena Shizue, Pinto, Flavio Augusto Ismael, Oliveira, Thiago Bueno, Salvadori, Marcela Marinelli
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Number of sites of metastasis (NSM) and progression-free survival (PFS) in patients (PTS) with melanoma treated with ipilimumab (IPI)
Tavares, Monique Celeste, De Barros E. Silva, Milton Jose, Rinck, Jose A., Urvanegia, Ana Claudia Machado, Macedo, Mariana Petaccia, Pinto, Clovis, Bezerra, Tiago, Dal Molin, Graziela Zibetti, Santos, Fábio Nasser, Yamamura, Rosely, Lima, Geraldine Eltz, Fanelli, Marcello Ferretti
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article